Relationship of Alcohol Intake With Inflammatory Markers and Plasminogen Activator Inhibitior-1 in Well-Functioning Older Adults: The Health, Aging, and Body Composition Study

Background—Increased levels of acute-phase reactants predict the onset of poor health outcomes. A U-shaped association has been reported between alcohol intake and health outcomes, which suggests that alcohol intake may modify levels of acute-phase reactants. We investigated the relationship between weekly alcohol intake and interleukin-6 (IL-6), C-reactive protein (CRP), tumor necrosis factor-&agr; (TNF-&agr;), and plasminogen activator inhibitor-1 (PAI-1). Methods and Results—Data are from year 1 of the Health, Aging, and Body Composition study, a biracial cohort of 3075 well-functioning men and women aged 70 to 79 years, living in Memphis, Tenn, and Pittsburgh, Pa. The analysis included 2574 persons (51.2% women; 40.1% black) with complete data. After adjustment for age, race, smoking status, history of diabetes, history of cardiovascular disease, physical activity, high-density lipoprotein cholesterol, antiinflammatory medications, statins, and total fat mass, alcohol intake showed a J-shaped relationship with mean IL-6 (P for quadratic term <0.001) and CRP (P =0.014) levels. The association was consistent in both men and women. Compared with subjects who consumed 1 to 7 drinks per week, those who never drank had an increased likelihood of having high levels of both IL-6 and CRP, as did those who drank 8 or more drinks per week. We found no relationship between alcohol intake and levels of TNF-&agr; and PAI-1 (P =0.137 and 0.08, respectively). Conclusions—In well-functioning older persons, light alcohol consumption is associated with lower levels of IL-6 and CRP. These results might suggest an additional biological explanation to the epidemiological link between moderate alcohol consumption and cardiovascular events.

[1]  J. M. Guralnik,et al.  Drug data coding and analysis in epidemiologic studies , 1994, European Journal of Epidemiology.

[2]  François Mach,et al.  Inflammation and Atherosclerosis , 2004, Herz.

[3]  Robert J Glynn,et al.  Alcohol Consumption and Plasma Concentration of C-Reactive Protein , 2003, Circulation.

[4]  A. Mainous,et al.  Relation between alcohol consumption and C-reactive protein levels in the adult US population. , 2002, The Journal of the American Board of Family Practice.

[5]  Licia Iacoviello,et al.  Meta-Analysis of Wine and Beer Consumption in Relation to Vascular Risk , 2002, Circulation.

[6]  Albert Hofman,et al.  Alcohol consumption and risk of dementia: the Rotterdam Study , 2002, The Lancet.

[7]  C. Kluft,et al.  Moderate alcohol consumption reduces plasma C-reactive protein and fibrinogen levels; a randomized, diet-controlled intervention study , 2002, European Journal of Clinical Nutrition.

[8]  J. Manson,et al.  Physical activity and coronary heart disease in women: is "no pain, no gain" passé? , 2001, JAMA.

[9]  H. Hendriks,et al.  Effect of Moderate Alcohol Consumption on Fibrinogen Levels in Healthy Volunteers Is Discordant with Effects on C‐Reactive Protein , 2001, Annals of the New York Academy of Sciences.

[10]  I-Min Lee,et al.  Physical Activity and Coronary Heart Disease in Women: Is No Pain, No Gain Passé? , 2001 .

[11]  Hermann Brenner,et al.  Effect of alcohol consumption on systemic markers of inflammation , 2001, The Lancet.

[12]  L. Ferrucci,et al.  Cardiovascular Disease, Interleukin-6, and Risk of Mortality in Older Women: The Women’s Health and Aging Study , 2001, Circulation.

[13]  H. Tilg,et al.  Cytokines in alcoholic and nonalcoholic steatohepatitis. , 2000, The New England journal of medicine.

[14]  P. Grant,et al.  Plasminogen-activator inhibitor type 1 and coronary artery disease. , 2000, The New England journal of medicine.

[15]  S. Humphries,et al.  Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? , 2000, Atherosclerosis.

[16]  K. Uysal,et al.  Tumor necrosis factor α is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1 , 1999 .

[17]  M. McCarty Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: down-regulation with essential fatty acids, ethanol and pentoxifylline. , 1999, Medical hypotheses.

[18]  I. Kushner,et al.  Acute-phase proteins and other systemic responses to inflammation. , 1999, The New England journal of medicine.

[19]  K. Uysal,et al.  Tumor necrosis factor alpha is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[20]  D. Papanicolaou,et al.  The Pathophysiologic Roles of Interleukin-6 in Human Disease , 1998, Annals of Internal Medicine.

[21]  M. McConnell,et al.  Effects of a single, daily alcoholic beverage on lipid and hemostatic markers of cardiovascular risk. , 1997, The American journal of cardiology.

[22]  I. Deaciuc,et al.  Effect of chronic alcohol consumption by rats on tumor necrosis factor-α and interleukin-6 clearance in vivo and by the isolated, perfused liver , 1996 .

[23]  J. Monasterio,et al.  Inflammatory mediators and their influence on haemostasis. , 1994, Haemostasis.

[24]  C M Burchfiel,et al.  A Prospective Study of the Health Effects of Alcohol Consumption in Middle‐Aged and Elderly Men: The Honolulu Heart Program , 1994, Circulation.

[25]  J F Sallis,et al.  Compendium of physical activities: classification of energy costs of human physical activities. , 1993, Medicine and science in sports and exercise.

[26]  M. Alessi,et al.  Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. , 1988, Blood.